Gout Drug Uloric Linked to Heart Attack Risk
Growing attention on Uloric heart problems raises the potential of litigation over the manufacturer's apparent failure to warn about the gout drug's risks.
Growing attention on Uloric heart problems raises the potential of litigation over the manufacturer's apparent failure to warn about the gout drug's risks.
Public Citizen is calling for a Uloric recall following additional evidence linking the gout drug to cardiovascular death.
FDA advisors call for Uloric to be a second-line gout treatment, saying the heart risks are too dangerous for most patients.
A new study warns that the side effects of Uloric may incrase the risk of death due to cardiovascular problems when compared to competing gout medications.
The FDA has launched an investigation into the side effects of Uloric after safety signals indicated it could increase the risk of cardiovascular deaths.
While concerns grew among consumers and the medical community over the risk of heart problems from Avandia, Takeda Pharmaceuticals was allegedly hiding evidence that their competing diabetes drug, Actos, was…
A whistleblower lawsuit accuses Takeda Pharmaceuticals of hiding potentially harmful side effects of Uloric, a gout medication.